Researchers at NREL found that UV exposure can cause significant, partly non-recoverable degradation in TOPCon solar cells, ...
Expands availability of Nociscan in the greater Los Angeles areaReinforces Nociscan’s non-invasive advantage with real-world clinical validation compared to anesthetic discography, a spinal injection ...
“If toy agents on a Reddit clone can create this much chaos, what happens when agentic systems manage enterprise infrastructure or financial transactions?" ...
Dow Jones Top Company Headlines at 5 AM ET: Google Is Spending Big to Build a Lead in the AI Energy Race | Nintendo ... A deal to buy wind and solar developer Intersect is the latest in a series of ...
Good day, everyone, and welcome to Pfizer's Fourth Quarter 2025 Earnings Conference Call. Today's call is being recorded. At ...
The stuff on the street is getting more dangerous, which is partly why Phoenix saw nearly 6,000 opioid overdoses in 2025.
GTB-5550 Phase 1 dose escalation basket trial expected to initiate mid-2026 Phase 1 protocol allows multiple solid tumor ...
Amgen Inc. ( AMGN) Q4 2025 Earnings Call February 3, 2026 4:30 PM EST ...
BPC-157 hasn't been approved by the FDA. But that hasn't stopped this buzzy drug from gaining traction – and attention from ...
Australia benchtop laboratory water purifier market is projected to reach USD 41.1 Mn by 2036, expanding at a CAGR of 6.5% from 2026 to 2036 ...
GTB-5550 Phase 1 dose escalation basket trial expected to initiate mid-2026 Phase 1 protocol allows multiple solid tumor types known to express B7-H3 Unaudited proforma cash balance as of January 31 ...
Pfizer Inc. (PFE) released mid-stage clinical trial data for its high-profile obesity drug candidate PF-3944 on Tuesday, sending its shares down more than 3%. The data presented a classic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results